Long-term efficacy of the pelvic floor muscle rehabilitation for women with stress urinary incontinence
Xiulan Zhang,Wenzhen Zhong,Wenguang Yan,Xuhong Li,Zhaojun Wang,Li Jiang,Hong Zhang
DOI: https://doi.org/10.11817/j.issn.1672-7347.2023.220401
2023-03-28
Abstract:Objectives: Stress urinary incontinence is a common disease with many therapeutic ways, but it lacks long-term follow-up. This study aims to conduct a retrospective study on the long-term efficacy of women with mild and moderate stress urinary incontinence after pelvic floor rehabilitation treatment for 3-years so as to provide a more effective treatment plan for this disease. Methods: Data were collected from 279 female patients, who were diagnosed with stress urinary incontinence at the Pelvic Floor Rehabilitation Center of the Third Xiangya Hospital of Central South University from January 2017 to January 2019. All patients received health education and were instructed to perform Kegel exercises for 20 min daily at home. According to the treatment pattern, patients were divided into 3 groups as A, B, and C. Group A (n=94) received pelvic floor biofeedback, electrical stimulation and electroacupuncture; Group B (n=99) received pelvic floor biofeedback and electrical stimulation; Group C (n=86) only got pelvic floor function examinations and did not receive any pelvic floor treatment. The pelvic floor functional examinations included a pelvic floor electrophysiological test, pelvic organ prolapse quantitive examination (POP-Q), and stress urinary incontinence severity assessment. All patients were followed up with questionnaire consisting of the International Committee on Urinary Incontinence Questionnaire-Short Form (ICI-Q-SF) and the Quality of Life questionnaire of Urinary Incontinence (I-QOL) before and after the treatment, as well as at 1-, 2-, and 3-years after the treatment (5 times in total). Among the patients who received the treatment, 43 returned to the hospital, including 21 in group A (Group Areturn) and 22 in group B (Group Breturn). Pelvic floor electrophysiological test and POP-Q were performed on the 2 groups. Results: For the leakage rate at the end of the treatment and the following 1-, 2-, and 3-years: Group A<Group B<Group C, and the recurrence rate of their leakage remained stable after 2 to 3 years of the treatment (P<0.05). Meanwhile, there was no significant difference in the I-QOL scores between Group A and Group B at the end of the treatment (P>0.05), but the I-QOL scores of Group A and Group B were much higher than that in Group C (both P<0.05). On the other hand, the I-QOL scores at 1-, 2-, and 3-years after the treatment were Group A>Group B>Group C (all P<0.05). In addition, the ICI-Q-SF scores at the end of the treatment and 1-, 2-, and 3-years after the treatment were Group A<Group B<Group C (P<0.05). There was also a significant effect of delivery on I-QOL and ICI-Q-SF scores after the treatment (P<0.05). Besides, the production method also had an impact on the ICI-Q-SF scores after the treatment (P<0.05). The results of the re-evaluation showed that there was no significant difference in the anterior vaginal wall prolapse score (point Aa) between Group A return and Group Breturn at the end of the treatment, but 3 years later, the score of anterior vaginal wall prolapse in Group Areturn was less than that in Group Breturn (P<0.05). Besides, no significant difference was found in the pelvic floor muscle strength between Group A return and Group Breturn at the end of the treatment (P>0.05). While the pelvic floor muscle strength in Group Areturn was much higher than that in Group Breturn (P<0.05) after 3 years of the treatment. What's more, the pelvic floor muscle potential in Group Areturn was much higher than that in Group Breturn (both P<0.05) at the end of the treatment and after 3 years of the treatment. Conclusions: Compared with pelvic floor biofeedback and electrical stimulation for stress urinary incontinence, electroacupuncture combined with pelvic floor electrical stimulation and biofeedback reveal more remarkable short-term efficacy and more stable long-term efficacy, which can significantly improve the quality of life in female patients.